NCT04326192 Brown Adipose Tissue Activation by Spinal Cord Stimulation
| NCT ID | NCT04326192 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Oregon Health and Science University |
| Condition | Pain, Back |
| Study Type | INTERVENTIONAL |
| Enrollment | 10 participants |
| Start Date | 2021-02-19 |
| Primary Completion | 2025-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 10 participants in total. It began in 2021-02-19 with a primary completion date of 2025-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The objective of this study is to investigate and utilize spinal cord stimulation (SCS) as an effective approach to eliciting weight loss and potentially alleviating Type 2 diabetes mellitus (DM), as evidenced by increasing metabolism of adipose tissue.
Eligibility Criteria
Inclusion Criteria: 1. Age: 21-70 years 2. Persistent neuropathic leg and back pain 3. Subjects who are already planning to undergo SCS for pain 4. Subjects who have not received a prior SCS trial for pain 5. Subjects with a BMI of 25-45, using formula; weight (lb) / \[height (in)\]2 x 703 Exclusion Criteria: 1. Not considering SCS for pain 2. Forensic patient 3. Taking beta blockers 4. Weight change \> 5% within last 3 months 5. Habitual tobacco use 6. Habitual excessive alcohol use 7. Pregnancy 8. Decisionally impaired adults 9. Children 10. Neonates 11. Subjects with a BMI of \<25 or \>45
Contact & Investigator
Kim Burchiel, MD
PRINCIPAL INVESTIGATOR
Oregon Health and Science University
Frequently Asked Questions
Who can join the NCT04326192 clinical trial?
This trial is open to participants of all sexes, aged 21 Years or older, up to 70 Years, studying Pain, Back. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04326192 currently recruiting?
Yes, NCT04326192 is actively recruiting participants. Contact the research team at burchiek@ohsu.edu for enrollment information.
Where is the NCT04326192 trial being conducted?
This trial is being conducted at Portland, United States.
Who is sponsoring the NCT04326192 clinical trial?
NCT04326192 is sponsored by Oregon Health and Science University. The principal investigator is Kim Burchiel, MD at Oregon Health and Science University. The trial plans to enroll 10 participants.